Evidence map›Paper›PMID 34198909›Full record

ReviewMolecules (Basel, Switzerland)2021

Activity and Mechanism of Action of Antifungal Peptides from Microorganisms: A Review.

Tianxi Li, Lulu Li, Fangyuan Du, Lei Sun, Jichao Shi, Miao Long, Zeliang Chen

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 111 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Frontiers in microbiology · 2026
    Article
  10. CLEC3A-derived peptides exhibit broad-spectrum activity againstFrontiers in cellular and infection microbiology · 2026
    Article
  11. Repositioning Antimicrobial Peptides Against WHO-Priority Fungi.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Kynurenine monooxygenaseFrontiers in microbiology · 2025
    Article
  18. Article
  19. Volatile Organic Compounds Produced by Co-Culture ofInternational journal of molecular sciences · 2024
    Article
  20. A Rhein-Based Derivative TargetsAntibiotics (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Tianxi LiCollege of Animal Science & Veterinary Medicine, Shenyang Agricultural University, Shenyang 110866, China.
Lulu LiCollege of Animal Science & Veterinary Medicine, Shenyang Agricultural University, Shenyang 110866, China.
Fangyuan DuCollege of Animal Science & Veterinary Medicine, Shenyang Agricultural University, Shenyang 110866, China.
Lei SunCollege of Animal Husbandry and Veterinary Medicine, Jinzhou Medical University, Jinzhou 121001, China.
Jichao ShiLiaoning Agricultural Development Service Center, Shenyang 110032, China.
Miao LongCollege of Animal Science & Veterinary Medicine, Shenyang Agricultural University, Shenyang 110866, China.ORCID 0000-0001-6683-1956
Zeliang ChenCollege of Animal Science & Veterinary Medicine, Shenyang Agricultural University, Shenyang 110866, China.
Shenyang Agricultural University · CNJinzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Harmful fungi in nature not only cause diseases in plants, but also fungal infection and poisoning when people and animals eat food derived from crops contaminated with them. Unfortunately, such fungi are becoming increasingly more resistant to traditional synthetic antifungal drugs, which can make prevention and control work increasingly more difficult to achieve. This means they are potentially very harmful to human health and lifestyle. Antifungal peptides are natural substances produced by organisms to defend themselves against harmful fungi. As a result, they have become an important research object to help deal with harmful fungi and overcome their drug resistance. Moreover, they are expected to be developed into new therapeutic drugs against drug-resistant fungi in clinical application. This review focuses on antifungal peptides that have been isolated from bacteria, fungi, and other microorganisms to date. Their antifungal activity and factors affecting it are outlined in terms of their antibacterial spectra and effects. The toxic effects of the antifungal peptides and their common solutions are mentioned. The mechanisms of action of the antifungal peptides are described according to their action pathways. The work provides a useful reference for further clinical research and the development of safe antifungal drugs that have high efficiencies and broad application spectra.

Indexed as

AnimalsAntifungal AgentsAntimicrobial Cationic PeptidesDrug DevelopmentDrug Resistance, Multiple, FungalDrug StabilityHumansMycosesPlant DiseasesAntifungal AgentsAntimicrobial Cationic Peptidesantibacterial activityantibacterial stabilityantifungal mechanismantifungal peptidecytotoxicity

Identifiers

PMID34198909
PMCPMC8201221
OpenAlexW3171558914

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.